Standard Biocompatibility Studies Do Not Predict All Effects of PVA/CMC Anti-Adhesive Gel in vivo

Abstract

Purpose: PVA/CMC (polyvinyl alcohol/carboxymethyl cellulose) hydrogel fulfills various physiochemical properties required for an adhesion barrier and has shown good anti-adhesion properties in previous in vivo studies. In this investigation, we assessed the in vitro and in vivo biocompatibility of PVA/CMC gel and compared this to the functionality and promotion of wound healing for two surgical indications. Methods: Standardized ISO10993 in vitro and in vivo biocompatibility studies, comprising cytotoxicity, genotoxicity, acute systemic toxicity, delayed contact and maximization sensitization test, intracutaneous reactivity and local muscle implantation, were performed on PVA/CMC gel. In the functional studies, PVA/CMC gel was applied - on the one hand - to a rabbit abdominal wall model enforced with a polypropylene mesh for testing the anti-adhesion properties and - on the other hand - to an end- to-end anastomosis model that was selected for surveying potential influences of different dosages of PVA/CMC gel on anastomotic wound healing. Results: The ISO10993 methods indicated generally good biocompatibility properties, such as the absence of cytotoxic and mutagenic effects as well as no signs of systemic toxicity and sensitization potentials. No irritation effects were observed after the intracutaneous injection of lipophilic PVA/CMC sesame oil extract. However, the injection of hydrophilic PVA/CMC physiologic saline extract induced slight irritation. Following rabbit muscle implantation of the PVA membrane for 2, 4, 12, 26 and 52 weeks, a slight irritant effect was observed at 12 weeks due to the peak of phagocytosis. In the functionality tests, PVA/CMC gel showed good anti-adhesive effects in the abdominal wall model enforced with the mesh, with significantly lower and less tense adhesions compared to the untreated control. However, moderate signs of inflammation, especially in the spleen were observed after the intra-abdominal implantation of 3.3 ml PVA/CMC gel per kg body weight. In the end-to-end anastomosis model, PVA/CMC gel had no influence on wound healing. For dosages of 1-6 ml gel per treatment, no signs of intestinal leaks were detected, and tensile strength was equal to that of the untreated control, but again more moderate signs of inflammation in the spleen were observed at a dosage >3 ml. Conclusion: Comparing the standardized ISO10993 methods, anti-adhesive PVA/CMC gel displays good biocompatibility. However, those methods do not seem to be sensitive enough because the rabbit abdominal wall and the end-to-end anastomosis models display more effects with respect to the dosage and routes of the intra-abdominal resorption of PVA/CMC gel - with the recommended <2 ml PVA/CMC gel per kg body weight as a secure dosage.

Surface Modification of Artificial Implants by Hybrid Nanolayers: Antimicrobial Surface Finishing and Strength Tests

“…Therefore, this could be a method easily applicable during production, financially undemanding, and leading to the obtaining of materials with significant added value after confirming improved antibacterial properties and screening out implant toxicity with the mentioned surface modification by our other research. Also, research on the change in the antiadhesive properties of the material after treatment with the solgel method could provide interesting results [46,[100][101][102][103][104][105][106][107][108][109][110][111].…”

Biomaterials to Prevent Post-Operative Adhesion

“…Polyvinyl alcohol (PVA) has the formula [CH 2 CH(OH)] n . PVA is a water-soluble, semi-crystalline polymer that has excellent thermal stability, physical properties, and biocompatibility and is inexpensive [ 113 , 114 ]. PVA has a strong oxygen barrier due to strong hydrogen bonds, but the presence of hydroxyl groups makes it very susceptible to moisture, causing swelling and dissolving.…”

Physicochemical Characterization, Biocompatibility, and Antibacterial Properties of CMC/PVA/Calendula officinalis Films for Biomedical Applications

“…Wound healing is one of the most complex and dynamic processes in the human body, involving homeostasis, inflammation, proliferation, and the remodeling of skin tissue [ 1 ]. However, wound healing is easily affected and delayed in patients with diabetes mellitus and complicated systematic health conditions [ 2 , 3 ]. In addition, delays to wound healing significantly increase the risk of wound infection, which results in immune responses, tissue inflammation, and damage.…”